text
"['\n1. 요약재무정보\n※ 아래의 요약재무정보는 한국채택국제회계기준 작성기준에 따라 작성되었으며 외부회계법인의 감사를 받은 재무정보입니다. \n\xa01.연결요약재무상태표 , 연결요약손익계산서\xa0\xa0\xa0 * 비교표시된 전기 및 전전기 재무정보는 재작성된 재무정보입니다.\n(단위 : 천원)\n구 분\n제4기\n제3기\n제2기\n[유동자산]\n277,512,818\n264,134,194\n273,355,962\n\xa0ㆍ매출채권및\xa0 \xa0 \xa0 \xa0 기타수취채권\n156,922,345\n161,883,123\n176,114,463\n\xa0ㆍ기타유동자산\n120,590,473\n102,251,071\n97,241,499\n[비유동자산]\n132,150,479\n136,261,645\n127,541,660\n\xa0ㆍ유형자산\n115,547,198\n120,438,216\n119,446,192\n\xa0ㆍ기타비유동자산\n16,603,281\n15,823,429\n8,095,468\n자산총계\n409,663,297\n400,395,839\n400,897,622\n[유동부채]\n218,058,270\n208,519,278\n194,556,097\n\xa0ㆍ매입채무및\xa0 \xa0 \xa0 \xa0 기타채무\n157,819,680\n172,009,099\n155,873,643\n\xa0ㆍ기타유동부채\n60,238,590\n36,510,179\n38,682,454\n[비유동부채]\n19,125,739\n23,021,557\n23,412,481\n부채총계\n237,184,009\n231,540,835\n217,968,578\n[자본금]\n7,352,436\n7,352,436\n7,352,436\n[자본잉여금]\n149,116,809\n149,115,172\n149,115,172\n[기타자본항목]\n(3,621,961)\n(3,307,081)\n(311,843)\n[기타포괄손익]\n16,706,152\n16,874,160\n14,751,221\n[이익잉여금]\n2,840,808\n(1,179,683)\n12,022,058\n[비지배지분]\n85,044\n-\n-\n자본총계\n172,479,288\n168,855,004\n182,929,044\n종속.관계.공동기업투자주식의 평가방법\r\n지분법\xa0\n지분법\xa0\n지분법\xa0\n(2020.1.1.~2020.12.31\n(2019.1.1.~2019.12.31\n(2018.1.1.~2018.12.31)\n매출액\n691,324,837\n671,406,875\n627,074,758\n영업이익\n12,904,373\n234,016\n6,355,082\n당기순이익\n6,964,802\n(10,239,417)\n(5,012,973)\n\xa0 지배기업 소유주지분\n6,916,121\n(10,239,417)\n(5,012,973)\n\xa0 비지배지분\n48,681\n-\n-\n기타포괄손익\n(2,040,626)\n36,341\n13,440,641\n총포괄손익\n4,924,176\n(10,203,076)\n8,427,668\n\xa0 지배기업 소유주지분\n4,875,495\n(10,203,076)\n8,427,668\n\xa0 비지배지분\n48,681\n-\n-\n기본주당이익(원)\n473\n(698)\n(376)\n희석주당이익(원)\n473\n(698)\n(376)\n연결에 포함된 회사수\n1\n0\n0\n\xa0* 연결에 추가 포함된 회사는 종속회사인 제일약품(주)의 종속회사인 온코닉 테라퓨틱스가 추가된 것임\xa02.요약별도재무상태표 , 요약별도손익계산서\xa0 \xa0\xa0\n(단위 : 천원)\n구 분\n제4기\n제3기\n제2기\n[유동자산]\n276,994,931\n264,134,194\n273,355,962\n\xa0ㆍ매출채권및\xa0 \xa0 \xa0 \xa0 기타수취채권\n156,777,515\n161,883,123\n176,114,463\n\xa0ㆍ기타유동자산\n120,217,416\n102,251,071\n97,241,499\n[비유동자산]\n134,474,210\n136,261,645\n127,541,660\n\xa0ㆍ유형자산\n115,428,281\n120,438,216\n119,446,192\n\xa0ㆍ기타비유동자산\n19,045,929\n15,823,429\n8,095,468\n자산총계\n411,469,141\n400,395,839\n400,897,622\n[유동부채]\n217,698,190\n208,519,278\n194,556,097\n\xa0ㆍ매입채무및\xa0 \xa0 \xa0 \xa0 기타채무\n157,470,338\n172,009,099\n155,873,643\n\xa0ㆍ기타유동부채\n60,227,852\n36,510,179\n38,682,454\n[비유동부채]\n19,125,739\n23,021,557\n23,412,481\n부채총계\n236,823,929\n231,540,835\n217,968,578\n[자본금]\n7,352,436\n7,352,436\n7,352,436\n[자본잉여금]\n149,115,172\n149,115,172\n149,115,172\n[기타자본항목]\n(3,621,961)\n(3,307,081)\n(311,843)\n[기타포괄손익]\n16,706,152\n16,874,160\n14,751,221\n[이익잉여금]\n5,093,413\n(1,179,683)\n12,022,058\n자본총계\n174,645,212\n168,855,004\n182,929,044\n종속.관계.공동기업투자주식의 평가방법\r\n지분법\n지분법\n지분법\xa0\n(2020.1.1.~2020.12.31)\n(2019.1.1.~2019.12.31)\n(2018.1.1.~2018.12.31)\n매출액(영업수익)\n692,224,837\n671,406,875\n627,074,758\n영업이익(손실)\n15,113,130\n234,016\n6,355,082\n당기순이익\n9,168,726\n(10,239,417)\n(5,012,973)\n기타포괄손익\n(2,040,626)\n36,341\n13,440,641\n총포괄손익\n7,128,099\n(10,203,076)\n8,427,668\n기본주당이익(원)\n627\n(698)\n(376)\n희석주당이익(원)\n627\n(698)\n(376)\n']"
